Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,348 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Prospective Randomized, Double-Blind, Multi-Center, Phase III Clinical Trial Evaluating the Efficacy and Safety of Olmesartan/Amlodipine plus Rosuvastatin Combination Treatment in Patients with Concomitant Hypertension and Dyslipidemia: A LEISURE Study.
Jo SH, Kang SM, Yoo BS, Lee YS, Youn HJ, Min K, Yu JM, Yoon HJ, Kim WS, Kim GH, Park JH, Kim SY, Kim CH. Jo SH, et al. Among authors: kim gh, kim ch, kim sy, kim ws. J Clin Med. 2022 Jan 11;11(2):350. doi: 10.3390/jcm11020350. J Clin Med. 2022. PMID: 35054044 Free PMC article.
Real-world evidence on the strategy of olmesartan-based triple single-pill combination in Korean hypertensive patients: a prospective, multicenter, observational study (RESOLVE-PRO).
Sohn IS, Ihm SH, Kim GH, Park SM, Hong BK, Lee CH, Lee SH, Chang DI, Joo SP, Lee SC, Lee YH, Jeon DW, Jung KT, Rhee SJ, Cho YJ, Kim CJ; Investigators. Sohn IS, et al. Among authors: kim gh, kim cj. Clin Hypertens. 2021 Nov 1;27(1):21. doi: 10.1186/s40885-021-00177-z. Clin Hypertens. 2021. PMID: 34719392 Free PMC article.
Real-World Effectiveness and Safety of a Single-Pill Combination of Olmesartan/Amlodipine/Hydrochlorothiazide in Korean Patients with Hypertension and Cardiovascular Risk Factors.
Oh J, Kim W, Kim GH, Kim HL, Park SD, Min KW, Hyun D, Hong JH, Lim S, Shin J; RESOLVE-INT Investigators. Oh J, et al. Among authors: kim gh, kim w, kim hl. Adv Ther. 2023 Nov;40(11):4817-4835. doi: 10.1007/s12325-023-02632-9. Epub 2023 Aug 31. Adv Ther. 2023. PMID: 37651078 Free PMC article.
2,348 results